Vivekanand Jha's Publications
About Vivekanand Jha's Publications
Executive Director, The George Institute for Global Health, India- PHD
-
Assisted peritoneal dialysis: Position paper for the ISPD
Peritoneal Dialysis International: Journal of the International Society for Peritoneal Dialysis Date published: -
Dialysis outcomes across countries and regions: A global perspective from the ISN-GKHA study
Kidney International Reports Date published: -
Key points in managing PLA2R-associated membranous nephropathy
Kidney International Reports Date published: -
Organization and Structures for Detection and Monitoring of CKD Across World Countries and Regions: Observational Data From a Global Survey
American Journal of Kidney Diseases Date published: -
#123 Impact of atacicept on hematuria in IGA nephropathy: post-hoc analysis of the phase 2b ORIGIN study
Nephrology Dialysis Transplantation Date published: -
#812 Phase 2b ORIGIN study open label extension with atacicept in patients with IgA nephropathy and persistent proteinuria: week 72 interim analysis
Nephrology Dialysis Transplantation Date published: -
Access to and quality of elective care: a prospective cohort study using hernia surgery as a tracer condition in 83 countries
The Lancet Global Health Date published: -
Outcomes of primary membranous nephropathy refractory to immunosuppressants
Clinical Kidney Journal Date published: -
Rationale, design, and intervention development of a mobile health led primary care program for management of type 2 diabetes in rural Thailand: SMARThealth Diabetes study protocol (Preprint)
JMIR Research Protocols Date published: -
A new era in the science and care of kidney diseases
Nature Reviews Nephrology Date published: -
Chronic kidney disease and the global public health agenda: an international consensus
Nature Reviews Nephrology Date published: -
WCN24-956 CULTIVATING ECO-CONSCIOUS KIDNEY CARE: INTRODUCTION OF THE ISN EMERGING LEADERS PROGRAM ENVIRONMENTALLY SUSTAINABLE KIDNEY CARE TOOLKIT
Kidney International Reports Date published: -
WCN24-1414 ORIGIN 3: PIVOTAL PHASE 3 STUDY EVALUATING EFFECT OF ATACICEPT VS PLACEBO ON PROTEINURIA AND RENAL FUNCTION PRESERVATION IN IGA NEPHROPATHY
Kidney International Reports Date published: -
WCN24-1294 ATACICEPT REDUCES HEMATURIA AND SERUM GD-IGA1, BOTH ASSOCIATED WITH LONG-TERM RENAL OUTCOMES IN IGA NEPHROPATHY: 36-WEEK RESULTS FROM THE PHASE 2B ORIGIN STUDY
Kidney International Reports Date published: -
The Efficacy and Safety of Reduced-Dose Oral Methylprednisolone in High-Risk Immunoglobulin A Nephropathy
Kidney International Reports Date published: -
WCN24-1278 Climate change, kidney care, and sustainability: A KAP survey of health professionals
Kidney International Reports Date published: